Clinical Research Division, Fred Hutch
Dr. Sherilyn Tuazon is developing better treatments for people with multiple myeloma. Her primary research goal is to create novel cellular therapies that provide lasting remissions and cures for patients with this currently incurable cancer. Her focus is on blood stem cell transplantation and immunotherapies, such as genetically modified T-cell therapies and a form of targeted radiation called radioimmunotherapy. Dr. Tuazon is also a physician who cares for patients with myeloma and other disorders of the blood’s plasma cells.
University of Washington
Fellowship in Hematology/Oncology, University of Washington/Fred Hutchinson Cancer Research Center, 2018
M.D. (Magna Cum Laude), University of Santo Tomas, Manila, Philippines, 2006
Multiple myeloma and other plasma cell disorders
Blood and marrow transplantation
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.